Ahmed Naguy
Overview
Explore the profile of Ahmed Naguy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
227
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naguy A, Alablani D, Alamiri B
Psychopharmacol Bull
. 2025 Feb;
55(2):80-84.
PMID: 39935667
Fixed-dose combinations were, and still, quite in vogue in medical practice but for better or worse, did not gain a foothold in psychiatric prescriptions. Whilst briefing the merits and demerits...
2.
Peterson G, Byrne K, Dillon T, Naguy A, Turnier-Shea Y, Rybak M, et al.
Psychopharmacol Bull
. 2025 Feb;
55(2):100-103.
PMID: 39935665
Objective: A patient with major depressive disorder (MDD) was receiving transcranial magnetic stimulation (TMS). A little over halfway through the course the patient was bereaved and experienced normal sadness. Our...
3.
Naguy A
Psychopharmacol Bull
. 2025 Feb;
55(2):75-79.
PMID: 39935664
High rates of both suicidality and NSSI in individuals with BPD indicate the severity of the distress experienced by many of those diagnosed. It behoves clinicians to delve into the...
4.
Naguy A, Alablani D, Alsalem N, Alamiri B
Am J Ther
. 2025 Feb;
PMID: 39918908
No abstract available.
5.
Pridmore S, Peterson G, Rybak M, Byrne K, Dillon T, Turnier-Shea Y, et al.
Australas Psychiatry
. 2025 Jan;
10398562251314301.
PMID: 39831586
Objective: To report the outcomes of transcranial magnetic stimulation (TMS) treatment of patients with acute major depressive disorder (MDD), with particular attention to the performance of the individual assessment tools,...
6.
Naguy A, Pridmore S, Yassin A, Alamiri B
Am J Ther
. 2025 Jan;
31(6):724-725.
PMID: 39792503
No abstract available.
7.
Naguy A, Pridmore S, Ozidu V, Alamiri B
Psychopharmacol Bull
. 2025 Jan;
55(1):64-69.
PMID: 39744410
Since its first inception by Kahlbaum in relation to schizophrenia, Catatonia syndrome is currently believed to cut across many neuropsychiatric diagnoses. In this focussed review, authors touch briefly on prevalence...
8.
Naguy A, Alayadhi N, Pridmore S, Alamiri B
Psychopharmacol Bull
. 2025 Jan;
55(1):89-92.
PMID: 39744408
Herein, authors report on an ASD child with comorbid ADHD, ID, metabolic syndrome and nocturnal enuresis that failed multiple trials of psychotropic agents for behavioural dyscontrol. Viloxazine adjuventia brought about...
9.
10.
Naguy A, Alayadhi N, Al-Tajali A, Ozidu V
Asian J Psychiatr
. 2024 Sep;
102:104249.
PMID: 39303333
As of August 2024, (US) FDA has granted approval for a number of psychotropic drugs on market that might usher an innovative sparkle in psychopharmacotherapy. This is a recap to...